Beijing Yongtai Ruike Biotechnology Company Ltd
2 clinical trials · Sponsor
◉ Watch Beijing Yongtai Ruike Biotechnology Company Ltd
| Record | Firm | Date |
|---|---|---|
| CAR-T-19 Injection in the Treatment of CD19-positive Relapsed/Refractory B-ALL (NCT06179524) | Beijing Yongtai Ruike Biotechnology Company Ltd | 2024-01-03 |
| Phase I Clinical Trial of RC19D2 Cell Injection in the Treatment of Diffuse Large B-cell Lymphoma (NCT06047197) | Beijing Yongtai Ruike Biotechnology Company Ltd | 2023-09-05 |
Track Beijing Yongtai Ruike Biotechnology Company Ltd automatically
Every clearance here is in the API, with alerts when new ones post.